AMARIN CORP PLC\UK Net Cash Provided by (Used in) Investing Activities, Continuing Operations
AMARIN CORP PLC\UK (AMRN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$12.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-02
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $0.00.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $0.00.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $0.00.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$12.00K.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$12.00K.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$21.00K.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$28.00K.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$14.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | -$12.00K 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | -$12.00K 10-Q · filed 2017-11-01 | -$12.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$12.00K 10-Q · filed 2017-08-02 | -$12.00K derived: sum of 3 quarters · filed 2018-05-02 | -$12.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | -$12.00K 10-Q · filed 2018-05-02 | -$12.00K derived: sum of 2 quarters · filed 2018-05-02 | -$12.00K derived: sum of 3 quarters · filed 2018-05-02 | -$12.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | -$21.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | -$21.00K 10-Q · filed 2017-11-01 | -$39.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$21.00K 10-Q · filed 2017-08-02 | -$39.00K derived: sum of 3 quarters · filed 2018-02-27 | -$49.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$21.00K 10-Q · filed 2017-05-03 | -$39.00K derived: sum of 2 quarters · filed 2018-02-27 | -$49.00K derived: sum of 3 quarters · filed 2018-02-27 | -$49.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$28.00K derived: sum of 2 quarters · filed 2018-02-27 | -$28.00K derived: sum of 3 quarters · filed 2018-02-27 | -$28.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$10.00K derived: sum of 2 quarters · filed 2016-11-03 | -$10.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | -$14.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | -$14.00K 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$14.00K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$14.00K 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | -$14.34M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |